TARE Procedure Cost in India

TARE Procedure Cost in India

The Estimated TARE Procedure Cost in India starts from USD 10000 TO USD 25000. The costs involved are determined by a variety of factors, including:

  • The hospital’s type and location.
  • The stage, type, and spread of liver cancer.
  • Overall patient condition.
  • Experience of the oncologist, radiologist, and surgeon.
  • Cost of hospitalization and further imaging procedures such as CT scans.


Transarterial Radioembolization (TARE) stands as an inventive therapeutic approach, seamlessly merging radiation therapy with embolization techniques to address liver tumors. Employing a minimally invasive methodology, TARE entails the introduction of Yttrium-90-laden microspheres into the blood vessels that intricately supply and nurture the burgeoning tumor.


The Transarterial Radioembolization (TARE) Procedure in India represents a pivotal treatment modality aimed at individuals grappling with liver cancer, scientifically termed Hepato Cellular Carcinoma (HCC). This avant-garde approach encompasses a minimally invasive treatment procedure executed through a transcatheter intra-arterial intervention, overseen by India’s preeminent Interventional Radiologist.


Comparatively evaluated against its counterparts in developed nations, the Cost of Transarterial Radioembolization Procedure in India emerges as notably economical. The comprehensive cost structure of this therapeutic regimen varies contingent upon the radiologist’s expertise and the specific nature and gravity of the tumor.

What Is TARE Procedure?

Transcatheter Intra-arterial Radioembolization (TARE) represents a procedural innovation harnessed by interventional radiologists to address both primary and secondary liver cancers. The TARE procedure involves the precise delivery of radioactive material directly into the liver tumor through the hepatic artery, achieved by a catheter placement in a peripheral artery. The introduced radioactive substance becomes concentrated within the tumor tissue, emitting targeted radiation that culminates in the demise of tumor cells.


Notably, the radioactivity contained within the infused beads administers potent radiation doses to malignant cells while sparing healthy tissues. This therapeutic approach holds particular significance for patients afflicted with multiple or inoperable liver tumors. It is essential, however, to underscore that TARE Therapy in India assumes a palliative role: while it extends and enhances the patient’s life, it does not effect a cure.


This specific procedure is termed Transarterial Radioembolization with yttrium-90 (TARE-Y90). The TARE Procedure in India finds utility in the subsequent scenarios:

  • It is considered for individuals diagnosed with unresectable Hepatocellular Carcinoma (HCC) and a prognosis of at least 3 months of survival.
  • Patients presenting with HCC localized to the liver and constituting less than 70% of the liver’s volume.
  • Those who are unsuitable candidates for surgical intervention or alternative treatments.
  • TARE can also serve as a viable substitute for ablation techniques and facilitate resection of stage-A tumors.
  • Notably, TARE exhibits a promising therapeutic impact, particularly among individuals exhibiting substantial vascular involvement.

Who May Need TARE Procedure

TARE  Procedure (Therapy) in India is only a palliative treatment. It may help to prolong the patient’s life and enhance overall quality of life, but it cannot cure the liver tumor. An oncologist may recommend TARE therapy in the following situations:

  • Patients who are unable to have surgery or a transplant.
  • Patients with primary or metastatic hepatocellular carcinoma (HCC).
  • Patients who have cholangiocarcinoma.

In particular circumstances, the patient may be advised against receiving treatment. These includes:

  • Patients who have extensive liver or kidney disorders.
  • Patients suffering from unconventional blood clotting.
  • Patients suffering from bile duct blockage.

Why Is Radioembolization Done?

Radioembolization can:

  • Shrink a tumor so it is easier to remove.
  • Kill cancer cells or slow cancer growth to give a child more time for a transplant organ to become available.
  • Help make symptoms better.

Radioembolization goes through a blood vessel and right to the liver tumor. The radioactive material doesn’t pass through healthy parts of the body to reach the cancer cells, as happens in other kinds of radiation treatments.

Sometimes doctors use radioembolization with other treatments, like chemotherapy and surgery.

Before Procedure?

The interventional radiologist will explain the risks and likely benefits of radioembolization. If you decide the procedure is right for your child, you’ll be asked to sign a consent (permission) form. Then, you will schedule the procedure.

Before the procedure, the care team will let you know:

  • if your child needs to stop any medicines
  • when your child should stop eating and drinking
  • whether your child will stay in the hospital or go home after the procedure
  • how to care for your child after the procedure

During the Procedure

Before the mapping operation begins, the patient will provide their informed consent, which includes detailed information about the TARE treatment.

An Interventional Radiologist in India will conduct a hepatic angiography to visualize the arterial structure within the liver and carefully coil the arteries connected to healthy organs and tissues.

In the course of Hepatic Angiography in India, a catheter will be introduced through a minor puncture in the patient’s groin. Additionally, the interventional radiologist will administer Tc99m AA, aiding in replicating the precise distribution pattern of TARE particles within the liver.

Subsequently, the patient will be discharged from the hospital and scheduled for a follow-up appointment after approximately one week.

During this interim, the interventional radiologist and nuclear medicine specialist will analyze the scans and imaging outcomes to ascertain the appropriate dosage of Y-90 to be administered inside the patient’s body.

For the subsequent stage of the procedure, the radiologist will employ the same catheter, inserting it into the hepatic artery. TARE particles, consisting of glass or resin beads infused with Yttrium-90—a radioactive substance with a gradual cancer cell-targeting effect—will then be introduced into the hepatic artery that leads to the tumors.

The duration of this treatment typically spans 3 to 4 hours, contingent upon the tumor’s location and severity.

After the Procedure

The patient will be hospitalized for 4-5 days following the procedure. This is important because the patient must be placed in radioactive isolation to protect others from unwanted radiation exposure.

Advantages of TARE Procedure?

Transarterial Radioembolization Procedure in India allows patients with complex or inoperable liver tumors to live for many months to several years longer. It also sets the path for an improved way of living.

In comparison to other radiation therapies, radioembolization has fewer severe side effects.

TARE doesn’t require any surgical incisions. A surgeon may make a small incision around the groin to place a catheter.

Radioembolization produces more radiation than any other external beam therapy.

Risks Associated with Transarterial Radioembolization?

Problems are not common, however they do occur on occasion. They may include the following:

  • Infection, hemorrhage, or blood vessel damage at the location where the catheter was inserted into the groin, as well as damage to other parts of the body (such as the lungs, stomach, colon, or pancreas) if the radiation moves beyond the targeted area.

  • Difficulties with the liver or gallbladder.

  • An allergic reaction to the contrast dye used to examine the blood arteries or a kidney disease.

  • Leukopenia is characterized by a decrease in the number of infection-fighting cells in the blood.

  • thrombocytopenia is characterized by a decrease in the number of blood clotting cells (platelets).